diabetic nephropathy

Open Access
Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
Rajiv Agarwal, Amer Joseph, Stefan D. Anker, Gerasimos Filippatos, Peter Rossing, Luis M. Ruilope, Bertram Pitt, Peter Kolkhof, Charlie Scott, Robert Lawatscheck, Daniel J. Wilson, George L. Bakris and on behalf of the FIDELIO-DKD Investigators

JASN January 2022, 33 (1) 225-237; DOI: https://doi.org/10.1681/ASN.2021070942

Add to Selected Citations
You have accessRestricted Access
CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease
Khurrum Shahzad, Sameen Fatima, Moh’d Mohanad Al-Dabet, Ihsan Gadi, Hamzah Khawaja, Saira Ambreen, Ahmed Elwakiel, Nora Klöting, Matthias Blüher, Peter P. Nawroth, Peter R. Mertens, Sven Michel, Frank Jaschinski, Richard Klar and Berend Isermann

JASN December 2021, 32 (12) 3066-3079; DOI: https://doi.org/10.1681/ASN.2021040431

Add to Selected Citations
You have accessRestricted Access
Coding Variants in Susceptibility to Diabetic Kidney Disease
Lili Liu and Krzysztof Kiryluk

JASN October 2021, 32 (10) 2397-2399; DOI: https://doi.org/10.1681/ASN.2021081088

Add to Selected Citations
You have accessRestricted Access
Association of Coding Variants in Hydroxysteroid 17-beta Dehydrogenase 14 (HSD17B14) with Reduced Progression to End Stage Kidney Disease in Type 1 Diabetes
Josyf C. Mychaleckyj, Erkka Valo, Takaharu Ichimura, Tarunveer S. Ahluwalia, Christian Dina, Rachel G. Miller, Ivan G. Shabalin, Beata Gyorgy, JingJing Cao, Suna Onengut-Gumuscu, Eiichiro Satake, Adam M. Smiles, Jani K. Haukka, David-Alexandre Tregouet, Tina Costacou, Kristina O’Neil, Andrew D. Paterson, Carol Forsblom, Hillary A. Keenan, Marcus G. Pezzolesi, Marlon Pragnell, Andrzej Galecki, Stephen S. Rich, Niina Sandholm, Ronald Klein, Barbara E. Klein, Katalin Susztak, Trevor J. Orchard, Ron Korstanje, George L. King, Samy Hadjadj, Peter Rossing, Joseph V. Bonventre, Per-Henrik Groop, James H. Warram and Andrzej S. Krolewski

JASN October 2021, 32 (10) 2634-2651; DOI: https://doi.org/10.1681/ASN.2020101457

Add to Selected Citations
You have accessRestricted Access
Correction: Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy
JASN October 2021, 32 (10) 2683; DOI: https://doi.org/10.1681/ASN.2021071000

Add to Selected Citations
You have accessRestricted Access
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes
Eiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, Manoj K. Gupta, Helen C. Looker, Jonathan M. Wilson, Zaipul I. Md Dom, Katsuhito Ihara, Kristina O’Neil, Bozena Krolewski, Caterina Pipino, Meda E. Pavkov, Viji Nair, Markus Bitzer, Monika A. Niewczas, Matthias Kretzler, Michael Mauer, Alessandro Doria, Behzad Najafian, Rohit N. Kulkarni, Kevin L. Duffin, Marcus G. Pezzolesi, C. Ronald Kahn, Robert G. Nelson and Andrzej S. Krolewski

JASN September 2021, 32 (9) 2331-2351; DOI: https://doi.org/10.1681/ASN.2021010105

Add to Selected Citations
You have accessRestricted Access
Could NAD⁺ Precursor Supplements Induce a Legacy of Protection against Diabetic Nephropathy?
Kelly A. Hyndman and Matthew D. Griffin

JASN June 2021, 32 (6) 1270-1273; DOI: https://doi.org/10.1681/ASN.2021020275

Add to Selected Citations
You have accessRestricted Access
Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy
Itaru Yasuda, Kazuhiro Hasegawa, Yusuke Sakamaki, Hirokazu Muraoka, Takahisa Kawaguchi, Ei Kusahana, Takashi Ono, Takeshi Kanda, Hirobumi Tokuyama, Shu Wakino and Hiroshi Itoh

JASN June 2021, 32 (6) 1355-1370; DOI: https://doi.org/10.1681/ASN.2020081188

Add to Selected Citations
You have accessRestricted Access
Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study
Sarah J. Schrauben, Haochang Shou, Xiaoming Zhang, Amanda Hyre Anderson, Joseph V. Bonventre, Jing Chen, Steven Coca, Susan L. Furth, Jason H. Greenberg, Orlando M. Gutierrez, Joachim H. Ix, James P. Lash, Chirag R. Parikh, Casey M. Rebholz, Venkata Sabbisetti, Mark J. Sarnak, Michael G. Shlipak, Sushrut S. Waikar, Paul L. Kimmel, Ramachandran S. Vasan, Harold I. Feldman, Jeffrey R. Schelling and on behalf of the CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators

JASN January 2021, 32 (1) 115-126; DOI: https://doi.org/10.1681/ASN.2020040487

Add to Selected Citations
You have accessRestricted Access
Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
Manga Motrapu, Monika Katarzyna Świderska, Irene Mesas, Julian Aurelio Marschner, Yutian Lei, Laura Martinez Valenzuela, Jia Fu, Kyung Lee, Maria Lucia Angelotti, Giulia Antonelli, Paola Romagnani, Hans-Joachim Anders and Lidia Anguiano

JASN August 2020, 31 (8) 1729-1745; DOI: https://doi.org/10.1681/ASN.2019070703

Add to Selected Citations

Main menu

User menu

Search

diabetic nephropathy

Pages

Articles

Information for Authors

About

Journal Information

More Information